- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Use of macrolides closely associated with sensorineural hearing loss: JAMA
A new study published in the Journal of American Medical Association suggests that in comparison to penicillin, outpatient oral macrolide usage was more likely associated with sensorineural hearing loss (SNHL) in children, adolescents, and young adults.
For adults with coexisting disorders, intravenous or high-dose macrolide treatment has been linked to the occasional development of sensorineural hearing loss; however, studies evaluating the auditory effects of oral outpatient dosage for children, adolescents, and young adults have been few. In order to ascertain if widespread outpatient use of oral macrolide treatment is linked to a higher incidence of juvenile SNHL by nationally representative analyses, Kirsten F. A. A. Dabekaussen and colleagues undertook this investigation.
875 matched pairs of kids, teens, and young adults who were matched for age, sex, and the amount of time since the prescription date were used in a retrospective case-control research. The TRICARE US military health insurance program's matched control participants, who were assessed between October 1, 2009, and September 30, 2014, were included with all eligible pediatric patients. When compared to the usage of penicillin among pediatric patients, exposure was conducted as an oral outpatient macrolide therapy. In terms of clinical outcomes, SNHL in children, adolescents, and young adults was of interest. After adjusting for other risk variables and possible confounders, multivariable conditional logistic regression was performed to compare the risk of past exposure to macrolides with that of prior exposure to penicillin. Additionally, four intervals between exposure and diagnosis were evaluated.
The key findings of this study were as follow:
1. 875 suitable matched pairs of children, teens, and young adults were composed.
2. The participants' average (standard deviation) age was 5.7 (4.9); 62% of them were male; 58 had Asian ancestry; 254 were Black; 1152 were White; and 286 belonged to Native American and other (no further breakdown was provided in the TRICARE database) racial and ethnic groups (16% ).
3. When all time frames from exposure were taken into account in the multivariable analysis, persons who had SNHL had higher probabilities of having had a prescription for a macrolide as opposed to a penicillin.
4. When diagnosis and testing took place more than 180 days after antibiotic exposure, the odds of being exposed to macrolides were considerably greater than those of being exposed to penicillin.
Reference:
Dabekaussen, K. F. A. A., Andriotti, T., Ye, J., Prince, A. A., Nguyen, L. L., Feng, A. Y., Chen, J. X., & Shin, J. J. (2022). Association of Outpatient Oral Macrolide Use With Sensorineural Hearing Loss in Children, Adolescents, and Young Adults. In JAMA Otolaryngology–Head & Neck Surgery. American Medical Association (AMA). https://doi.org/10.1001/jamaoto.2022.1293
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751